The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

(RW) post-progression outcomes following first-line (1L) ribociclib (RIB) + aromatase inhibitor (AI) versus AI alone in African American and low socio-economic status (SES) patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2–) metastatic breast cancer (MBC) in US.

Vk  Gadi

Stock and Other Ownership Interests  - 3rdEyeBio; Emerging Markets Cancer Ignition Fund; Novilla; Ozette; Phoenix Molecular Designs; TempusAI; XTRemisBio

Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Hologic; Novartis; Pfizer; Puma Biotechnology; Stemline Therapeutics

Speakers' Bureau - Bicycle Therapeutics; Hologic; Roche/Genentech

Research Funding - Agendia (Inst); BioNTech SE; Illumina (Inst); Lilly; Novartis

Travel, Accommodations, Expenses - Novartis; Pfizer; Puma Biotechnology; Stemline Therapeutics

Lowell  Hart

Consulting or Advisory Role - Novartis

Paolo  Tarantino

Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Genentech/Roche; Gilead Sciences; Lilly; Menarini; Novartis

Research Funding - AstraZeneca

Travel, Accommodations, Expenses - AstraZeneca

Priyanka  Sharma

Stock and Other Ownership Interests  - Amgen; Gilead Sciences (I); Johnson & Johnson/Janssen; Pfizer (I); Roche/Genentech (I); Sanofi

Consulting or Advisory Role - AstraZeneca; Boston Scientific (I); Cipla (I); Gilead Sciences; GlaxoSmithKline; Lilly; Merck; Novartis; Pfizer; Salient Pharmaceuticals (I); Sanofi; Stemline Therapeutics

Research Funding - Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst)

Patents, Royalties, Other Intellectual Property - UpToDate

Sarah  Sammons

Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Foundation Medicine; Incyclix Bio; Loxo/Lilly; Novartis; Pfizer; Relay Therapeutics; Sermonix Pharmaceuticals

Research Funding - AstraZeneca/MedImmune (Inst); Lilly (Inst); Relay Therapeutics (Inst); Relay Therapeutics (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst)

Panagiotis  Mavros

No Relationships to Disclose

Maneet  Kaur

Employment - Flatiron Health

Nada  Boualam

Employment - Flatiron Health

Catherine  Keane

Employment - Flatiron Health

Stock and Other Ownership Interests  - Roche

Research Funding - Flatiron Health

Gary  Sopher

Stock and Other Ownership Interests  - Novartis

Purnima  Pathak

Employment - Novartis

Stock and Other Ownership Interests  - Novartis

Hope  Rugo

Consulting or Advisory Role - BioNTech; Bristol Meyer; Helsinn Therapeutics; Napo Pharmaceuticals

Research Funding - Ambryx (Inst); AstraZeneca (Inst); Bicycle Therapeutics (Inst); Daiichi Sankyo (Inst); F. Hoffman-La Roche/Genentech (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Stemline Therapeutics (Inst)